A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The study was conducted to determine the long-term safety and efficacy of nebivolol in
patients with mild to moderate hypertension. This was an extension of the Phase III dose
ranging studies NEB 202, 302 and 305. Nebivolol was studied as monotherapy and in conjunction
with add-on antihypertensive therapy.